sorafenib pharmascience 200 mg filmsko obložene tablete
sorafenib - filmsko obložena tableta - sorafenib 200 mg / 1 tableta - sorafenib
sorafenib teva 200 mg filmsko obložene tablete
sorafenib - filmsko obložena tableta - sorafenib 200 mg / 1 tableta - sorafenib
sorafenib teva 200 mg filmsko obložene tablete
sorafenib - filmsko obložena tableta - sorafenib 200 mg / 1 tableta - sorafenib
klozapin accord 100 mg tablete
klozapin - tableta - klozapin 100 mg / 1 tableta - klozapin
sorafenib accord
accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastična sredstva - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.
amaryl 4 mg tablete
sanofi-aventis d.o.o. - glimepirid - tableta - glimepirid 4 mg / 1 tableta - glimepirid
amaryl 1 mg tablete
sanofi-aventis d.o.o. - glimepirid - tableta - glimepirid 1 mg / 1 tableta - glimepirid
amaryl 6 mg tablete
sanofi-aventis d.o.o. - glimepirid - tableta - glimepirid 6 mg / 1 tableta - glimepirid
amaryl 3 mg tablete
sanofi-aventis d.o.o. - glimepirid - tableta - glimepirid 3 mg / 1 tableta - glimepirid
amaryl 2 mg tablete
sanofi-aventis d.o.o. - glimepirid - tableta - glimepirid 2 mg / 1 tableta - glimepirid